Advertise on podcast: Adam Walker’s Pharma Prescribed Podcast

Sarah Browning | The Business Case for Kindness: Why Happier Teams Are 20% More Productive | Pharma Prescribed Sarah Browning is a "Kindness Cheerleader" with a 25-year career in internal communications and engagement. In 2021, after an afternoon of reflection on a bench by the River Thames, she founded the Time for Kindness wellbeing programme — built on a simple idea: there is far more kindness in the world than the headlines admit, and noticing it changes how people feel, and therefore how they perform. This episode is where that idea meets the evidence. Adam puts the data audience's challenge to Sarah directly — show me the numbers — and she answers: a University of Warwick study linking a culture of kindness to employees who were around 20% more productive; a Harvard finding that leaders who intentionally model kindness find their difficult conversations easier, because they've already built the trust those conversations stand on. Her through-line: kindness isn't weak and it isn't fluffy. It's an intentional, measurable business skill. From there the conversation gets practical. How to spot kindness in an ordinary working day. Why busyness is the enemy of noticing. The "hero stories" she collects and shares. Kindness ambassadors, team practices, and reframing the tough conversation as an act of respect rather than its opposite. And how all of this held up — or mattered more — through COVID. Honest, warm and rigorous in equal measure. A conversation that takes a soft-sounding word and makes a hard-edged case for it. 🎧 LISTEN TO THE AUDIO Spotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjti Apple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970 Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast Podbean: https://pharmaprescribed.podbean.com Full transcript and episode notes: https://pharmaprescribed.com/episodes 🔗 RELATED EPISODE Sarah's evidence-led case for kindness pairs directly with Graham Allcott (Think Productive) on KIND, psychological safety and the quiet power of kindness at work: ▶️ YouTube: https://youtu.be/1i1_TIZRBmI 🎧 Spotify: https://open.spotify.com/episode/04glB17p7bBWVmLjlwIO7z 🍎 Apple: https://podcasts.apple.com/gb/podcast/graham-allcott-on-kind-psychological-safety-the-quiet/id1829715970?i=1000778402287 ⏱️ CHAPTERS 0:00 Intro 0:35 Meet Sarah Browning 1:00 The Kindness Cheerleader mission 3:00 Kindness conference energy 4:00 Why kindness is powerful 6:00 The River Thames eureka moment 10:00 Defining kindness at work 14:00 The evidence: productivity and performance 17:00 Building kind cultures 20:00 Changing big organisations 23:00 A hero story in action 24:00 Team kindness practices 27:00 Reframing tough conversations 28:00 Kindness through COVID 31:00 Spotting kindness daily 35:00 Slow down, notice more 43:00 Kindness is contagious 46:00 Quickfire and wrap up 👤 ABOUT SARAH BROWNING Founder of the Time for Kindness wellbeing programme and a self-styled Kindness Cheerleader. Strategic communications consultant with 25 years in internal communications and engagement, and Internal Comms Manager for Staff Wellbeing at a Russell Group university. Speaker, storyteller and advocate for staff wellbeing as a core business measure. 💼 Search "Sarah Browning" on LinkedIn 🌐 https://www.timeforkindness.co.uk 🎙️ ABOUT PHARMA PRESCRIBED Pharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker. 🌐 https://pharmaprescribed.com ▶️ https://www.youtube.com/@pharmaprescribedpodcast 💼 https://www.linkedin.com/in/adamwalkerbiometrics 🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast #SarahBrowning #TimeForKindness #KindnessAtWork #WorkplaceWellbeing #Leadership #PharmaPrescribed #PsychologicalSafety #EmployeeEngagement #OrganisationalCulture #KindnessMatters #StaffWellbeing

Pavel Trofimov spent roughly 15 years in international B2B sales across complex technical markets before moving into clinical research — where he noticed something the industry treats as normal. Founders, scientists and operational leaders were doing the delivery and the business development themselves. In most other regulated industries, that commercial work sits with a dedicated team. That gap became Lab-2-Business (L2B). Pavel's mission, in his own words: to help excellent scientific and technological companies be as deliberate about winning business as they are about delivering it. In this episode he unpacks the imbalance at the heart of clinical research — delivery machines built to be precise and never make mistakes, with almost no one positioned to make the value clear and turn it into revenue. He's sharp on why founder-led growth hits a ceiling, why he refuses "twin mandates" (so he never becomes the networking "head that changes its body" at every conference), and why he rejects the word "fractional" altogether — he embeds as an extended team member, aligned on scope and outcomes, in it for the long run. The conversation's most provocative turn is on AI-native startups. Pavel argues they face a harder sell than anyone: they're not selling a product into the clinical trial ecosystem, they're selling behaviour change — convincing people to change how they work, measure and invoice. His prediction: once the early adopters move and the regulatory rules settle, the companies that move fastest could own the clinical trial market, and parts of the old industry may simply collapse. Adam and Pavel also trade notes on a live concern: AI "personas" now cold-approaching people on LinkedIn, and why validating that you're talking to a real human matters more than ever. A commercial lens on an industry that rarely applies one to itself. 🎧 LISTEN TO THE AUDIO Spotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjti Apple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970 Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast Podbean: https://pharmaprescribed.podbean.com Youtube: https://youtu.be/Fb4HYN0J6Zk  Full transcript and episode notes: https://pharmaprescribed.com/episodes ⏱️ CHAPTERS 0:00 Intro 0:35 Meet Pavel and Lab-2-Business 2:00 Spotting the commercial gap 4:00 The limits of founder-led growth 14:00 Embedded, not fractional 18:00 The pivot into life sciences 26:00 AI-native tools and selling behaviour change 35:00 Quickfire and golden rule 👤 ABOUT PAVEL TROFIMOV Founder of Lab-2-Business (L2B). Commercial specialist with ~15 years in international B2B sales across complex technical products and services, now focused on clinical research and life sciences. Works as an embedded commercial team member helping founder-led scientific and technology companies build deliberate, systematic business development — with particular interest in AI-native companies stripping manual work and friction out of clinical trials. 💼 Search "Pavel Trofimov" on LinkedIn 🎙️ ABOUT PHARMA PRESCRIBED Pharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker. 🌐 https://pharmaprescribed.com ▶️ https://www.youtube.com/@pharmaprescribedpodcast 💼 https://www.linkedin.com/in/adamwalkerbiometrics 🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast #PavelTrofimov #Lab2Business #ClinicalResearch #BusinessDevelopment #CommercialStrategy #PharmaPrescribed #AIinPharma #ClinicalTrials #FounderLedGrowth #B2BSales #LifeSciences

Henrik Nakskov | An AI Can't Ask Questions of the Future - Data Trust in Clinical Research | Pharma Prescribed Henrik Nakskov is a Danish life sciences specialist with more than 20 years in clinical drug development — a medical chemist by training who became one of the field's more original thinkers on data integrity. He spent a decade at Novo Nordisk in haematology and coagulation, held senior roles at NNIT, and led biometrics at Symphogen. That experience now runs through three companies: Sims Consult (his life sciences consultancy), Novyra Life Sciences (where he's CEO and Clinical Information Management Lead), and Safe Implant Technology (where he leads the science). Henrik cares more about where data comes from than almost anyone. In this episode he explains how he borrowed from Second World War supply-chain theory and Toyota's just-in-time management to rebuild the way trial data is collected and cleaned — taking last-patient-out to database release from a normal 8–12 weeks down to one week, and in some studies to two days. He tells the story of trauma trials collecting 1,102 data points in three hours under conditions of war and car accidents, and of mapping the full chain of a stroke patient's care — onset, admission, CT scan, treatment — so precisely the FDA used it to teach what data intelligence actually means. Then the conversation turns to AI, where Henrik is refreshingly precise. He runs Grok and ChatGPT against each other to hunt for the "black holes," builds explicit frameworks and guardrails so the models can't wander, and makes a sharp philosophical point: an AI can only work from references it has already learned — it cannot ask a genuinely new question of the future, so the more you use it, the more surveillance your safety monitoring needs to compensate for the unknowns you've introduced. Coaching over policing, trust over box-ticking, and a continuous-monitoring vision for where quality is heading. A masterclass for anyone who works with clinical data. 🎧 LISTEN TO THE AUDIO Spotify: https://open.spotify.com/episode/40WRQLAD3Ed6ibFV9Fm7wZ?si=QRbYluxTT-2E6O3jeGRWiA  Apple Podcasts: https://podcasts.apple.com/us/podcast/an-ai-cant-ask-questions-of-the-future-data/id1829715970?i=1000792188722  Podbean: https://pharmaprescribed.podbean.com Youtube: https://youtu.be/9ZbJ9PXOJBM  Full transcript and episode notes: https://pharmaprescribed.com/episodes ⏱️ CHAPTERS 0:00 Intro 0:35 Meet Henrik Nakskov 6:00 Faster trials, better quality 12:00 From Novo to consulting 16:00 Building Sims Consult 25:00 Culture and change management 34:00 Trust, standards and due diligence 39:00 Coaching, not policing 41:00 AI in clinical quality 42:00 Frameworks and guardrails 49:00 Why old-school approaches fail 51:00 The black-box risk problem 57:00 A continuous-monitoring vision 1:00 Quickfire and golden rule 👤 ABOUT HENRIK NAKSKOV Medical chemist and clinical data specialist with 20+ years in drug development. Former Project Data Manager at Novo Nordisk (haematology and coagulation), senior roles at NNIT, and biometrics lead at Symphogen. Founder of Sims Consult; CEO and Clinical Information Management Lead at Novyra Life Sciences; CEO and science lead at Safe Implant Technology. Specialist in data integrity, clinical informatics, quality management systems and the governed use of AI in regulated research. Occasional contributor to regulatory guidance. 💼 Search "Henrik Nakskov" on LinkedIn 🎙️ ABOUT PHARMA PRESCRIBED Pharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker. 🌐 https://pharmaprescribed.com ▶️ https://www.youtube.com/@pharmaprescribedpodcast 💼 https://www.linkedin.com/in/adamwalkerbiometrics 🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast #HenrikNakskov #DataIntegrity #ClinicalDataManagement #ClinicalTrials #AIinPharma #Biometrics #PharmaPrescribed #ClinicalInformatics #DataIntelligence #QMS #DrugDevelopment

Dr Sonit Handa | Building a Tumour tissue bank for $1M a day Children’s Cancer Research and Treatment Centre | Pharma Prescribed Dr Sonit Handa is the founder and CEO of Biovance Consulting, where he helps biopharma leaders navigate global launches, operating-model transformations and post-merger integrations. He trained as a physician in India, then moved to the United States — drawn to the intersection of medicine, science, technology and business. His path started with a swerve. Watching everyone around him in medical school run the same race toward the same specialties, Sonit went looking for the thing beyond traditional medicine. He found it in the late-90s wave of medical transcription being outsourced to India — his first glimpse of technology transforming healthcare — and followed it into biomedical and tissue engineering in the US. That led to St Jude Children's Research Hospital in Memphis: a non-profit where no family pays for treatment, funded entirely by donation to the tune of roughly a million dollars a day. Sonit was hired to build the operations of its tissue bank — 25 years of samples stored without a proper database — so researchers could actually find and request what they needed and turn it into discoveries for children with cancer. He's candid about how he got there: cold emails through the night, visa deadlines, and one CSO in the city he was already living in who wrote back. From there the conversation opens out into the ideas that run through his work: why culture is an emotion you feel, not a line in a job description; why EQ will matter as much as IQ for the next generation; why change management is the one discipline AI makes non-negotiable; and the ethics of drug pricing seen from both sides of the world. Warm, wide-ranging and genuinely reflective — a reminder that, looking back, the dots connect. 🎧 LISTEN TO THE AUDIO Spotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjti Apple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970 Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast Podbean: https://pharmaprescribed.podbean.com Full transcript and episode notes: https://pharmaprescribed.com/episodes 🔗 RELATED EPISODE Sonit and Adam return again and again to kindness and cultural fit — the same ground Graham Allcott (Think Productive) covers on KIND, psychological safety and the quiet power of kindness at work: ▶️ YouTube: https://youtu.be/1i1_TIZRBmI 🎧 Spotify: https://open.spotify.com/episode/04glB17p7bBWVmLjlwIO7z 🍎 Apple: https://podcasts.apple.com/gb/podcast/graham-allcott-on-kind-psychological-safety-the-quiet/id1829715970?i=1000778402287 ⏱️ CHAPTERS 0:00 Intro 0:35 Meet Dr Sonit Handa 1:00 Mission and approach 2:00 From India to the US 3:00 A tech spark in medicine 5:00 The St Jude tissue bank 8:00 Immigration and kindness 11:00 Choosing the MBA path 14:00 Building Biovance Consulting 16:00 Support and advice for students 22:00 AI, EQ and attention 28:00 A consultant's problem-solving 31:00 The change management playbook 41:00 Ethics and access 46:00 Quickfire and close 👤 ABOUT DR SONIT HANDA Founder and CEO of Biovance Consulting. Physician trained in India, with graduate study in biomedical and cell/tissue engineering in the US. More than two decades in life-science leadership across clinical development, regulatory affairs, market access, commercial operations and transformation. Advisor to biopharma leaders on aligning strategy with execution — global launches, operating-model change and post-merger integration. Mentor to students entering the field. 💼 Search "Sonit Handa" on LinkedIn 🌐 https://www.biovanceconsulting.com 🎙️ ABOUT PHARMA PRESCRIBED Pharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker. 🌐 https://pharmaprescribed.com ▶️ https://www.youtube.com/@pharmaprescribedpodcast 💼 https://www.linkedin.com/in/adamwalkerbiometrics 🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast #SonitHanda #BiovanceConsulting #StJude #ChangeManagement #LifeSciences #PharmaPrescribed #PharmaConsulting #EQatWork #AIandWork #MarketAccess #PostMergerIntegration

Gerrie Hawes on the HOPE Framework: How Behaviour, Not Strategy, Actually Changes Organisations | Pharma Prescribed Gerrie Hawes is a corporate behavioural psychologist who works in boardrooms and on stages, helping leaders turn strategy into behaviour people actually adopt. She's worked behind the scenes with most of the pharmaceutical companies you could name — a self-described "hidden person," which makes her a fitting guest for a podcast about hidden voices. She opens with a story that reframes the whole conversation. Coaching a global IT leader on her opening speech, Gerrie asked her a question no one asks an IT director: "Why do you work here — you could work anywhere?" The leader paused, reached into her handbag, and produced a family photograph. Lung cancer. "They're dead, and they're dead." She'd chosen that company because it was at the leading edge of the treatment. That, Gerrie told her, is what you tell your team — not the strategy, the why beneath it. From there Gerrie unpacks her HOPE framework — Happiness, Optimism, Playfulness, Empathy — a practitioner's model for the human dynamics that strategy decks miss. She explains why she hunts for a specific kind of laughter in the room (the edge between the learning zone and the panic zone), why happiness starts with the self but can't end there, and why empathetic leadership means understanding what drives other people, not assuming they're driven by what drives you. She's also clear-eyed on AI: the more it can do, the more the durable human advantage becomes the things it can't — playfulness, genuine empathy, reading the space between people. Plus boundaries, burnout, toxic cultures, upward empathy, and the quiet power of listening and introversion. A thoughtful, practical conversation about the behaviours that actually move organisations — long after the away-day is over. 🎧 LISTEN TO THE AUDIO Spotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjti  Apple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970  Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast  Podbean: https://pharmaprescribed.podbean.com  Full transcript and episode notes: https://pharmaprescribed.com/episodes 🔗 RELATED EPISODE If Gerrie's take on empathy and safe spaces resonated, hear productivity author Graham Allcott (Think Productive) on KIND, psychological safety and the quiet power of kindness at work: ▶️ YouTube: https://youtu.be/1i1_TIZRBmI  🎧 Spotify: https://open.spotify.com/episode/04glB17p7bBWVmLjlwIO7z  🍎 Apple: https://podcasts.apple.com/gb/podcast/graham-allcott-on-kind-psychological-safety-the-quiet/id1829715970?i=1000778402287  ⏱️ CHAPTERS 0:00 Intro 0:35 Meet Gerrie Hawes 4:00 Purpose and anti-purpose 6:00 Inside boardroom culture 18:00 Extreme role modelling 20:00 The HOPE framework explained 24:00 HOPE vs the AI advantage 28:00 Happiness as a value 30:00 Boundaries build respect 33:00 When work turns toxic 34:00 Objectives and upward empathy 37:00 Playfulness vs burnout 40:00 Safe spaces for honesty 45:00 Listening and introversion 47:00 Quickfire round 👤 ABOUT GERRIE HAWES Corporate behavioural psychologist specialising in change leadership and culture across pharma, consulting and global organisations. She helps senior teams turn strategy into adopted behaviour, and coaches speakers one-to-one on confidence, clarity and reading a room. Creator of the HOPE framework (Happiness, Optimism, Playfulness, Empathy). UK-based, working across global time zones. 💼 Search "Gerrie Hawes" on LinkedIn 🎙️ ABOUT PHARMA PRESCRIBED Pharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker. 🌐 https://pharmaprescribed.com  ▶️ https://www.youtube.com/@pharmaprescribedpodcast  💼 https://www.linkedin.com/in/adamwalkerbiometrics  🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast  #GerrieHawes #HOPEFramework #BehaviouralScience #Leadership #OrganisationalCulture #PharmaPrescribed #ChangeLeadership #EmpatheticLeadership #WorkplaceCulture #AIandWork #Burnout

Clive Bonny on Atrial Fibrillation, Blood Thinners & the "Sudden Death Syndrome" Nobody Checks For | Pharma Prescribed ⚠️ This episode discusses suicide and bereavement. If you're affected, please reach out to a professional or a crisis line — in the UK, Samaritans are available free on 116 123, day or night. Clive Bonny is a management consultant and business advisor of 36 years, specialising in responsible business standards, intellectual property protection and ethical, outcome-driven leadership. He's also a health advocate who lives with atrial fibrillation and is a prostate cancer survivor — and in this episode, business and biology meet. Clive and host Adam Walker discover how much they share: both live with AF, both lost a sibling to suicide, both were endurance athletes. That common ground makes for an unusually open conversation about what AF actually feels like, how it's diagnosed — often by accident — and why Clive calls it "sudden death syndrome": nearly a million people in the UK have it, and many don't know until it's too late. His practical message is simple: check your pulse, and if it's consistently low, ask for a test. Clive shares his own dramatic diagnosis — a resting pulse of 30 discovered on an operating table, two weeks in intensive care, heparin, cardioversion, a pacemaker and an ablation — the same ablation procedure Adam was himself about to undergo. Both discuss life on long-term anticoagulation (DOACs) and the different level of cardiac care that followed. The conversation ranges wider too: Clive's career innovating for Bayer and Hoechst, taking inventions through IP protection and clinical trials, robotic prostate surgery, and building social value through local volunteering. Honest, warm and genuinely useful — two patients comparing notes in public so others don't get caught out. 🎧 LISTEN TO THE AUDIO Spotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjti Apple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970 Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast Podbean: https://pharmaprescribed.podbean.com Full transcript and episode notes: https://pharmaprescribed.com/episodes ⏱️ CHAPTERS 0:00 Content warning 0:35 Intro 1:00 Meet Clive Bonny 1:30 Mission and values 3:00 Early influences 7:00 The open-minded connector 11:00 A career in pharma innovation 14:00 How the microcurrent device works 17:00 Living with atrial fibrillation 24:00 Adam's AF experience 26:00 Clive's prostate cancer story 32:00 Da Vinci robotic surgery 34:00 ESG and social value 37:00 Local volunteering wins 44:00 Life outside work 45:00 Golden rule 47:00 Closing and contact 👤 ABOUT CLIVE BONNY Management consultant and business advisor since 1990, specialising in responsible business standards, intellectual property protection, dispute resolution and cost-efficient operational strategy. Former innovation lead for Bayer and Hoechst. Board-level governance advisor and mediator. Health advocate living with atrial fibrillation and a prostate cancer survivor. 💼 Search "Clive Bonny" on LinkedIn https://consult-smp.com 🎙️ ABOUT PHARMA PRESCRIBED Pharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker. 🌐 https://pharmaprescribed.com ▶️ Youtube https://youtu.be/6ssayU4ouNc 💼 https://www.linkedin.com/in/adamwalkerbiometrics/ 🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast ℹ️ Nothing in this episode is medical advice. Views on treatments and devices are personal experience only — always consult a qualified clinician about your own care. #CliveBonny #AtrialFibrillation #AFib #DOAC #Anticoagulants #ProstateCancer #PharmaPrescribed #PatientVoice #HeartHealth #MedicalDevices #ResponsibleBusiness

Ashish Rishi on The Patients Clinical Trials Leave Out — and the Evidence That Counts Them In | Pharma Prescribed  Ashish Rishi is Founder and CEO of Unwritten Health, the Manchester-based patient experience data platform working to make life science's evidence reflect the people it's meant to serve. His mission is unsentimental — and it starts with his father. At 17, Ash watched his dad spend three years fighting for a GP referral for worsening back and bone pain. The eventual diagnosis was terminal prostate cancer, delivered to an 18-year-old and his mother — for whom English is a fourth language — in a two-minute conversation and a flyer, with no family network to turn to. His father lived six more years and passed away three months before Ash's graduation. That experience became a company. In this episode Ash explains "inclusion debt" — his term for how bias compounds at every stage of drug development: unmet need defined without the real patient voice, multi-billion-pound programmes built on focus groups of eight to ten patient experts, recruitment budgets thrown at social ads that reach the already-reachable, and value dossiers that carry only the majority narrative. By market access, it's too late to fix. The Patients Clinical Trials Leave Out — and the Evidence That Counts Them In His answer is Equity Engine: a 6,000-strong UK participant panel profiled across the social determinants of health, built through gurdwaras, mosques, temples, churches and community groups, generating longitudinal lived-experience data at a scale focus groups never could — and turning it into submission-ready evidence. Honest about being a "failed scientist," about burnout and anger, and about the trust he has to earn in every room. A powerful conversation about fixing inequity as an evidence and design problem, not just a moral one. 🎧 LISTEN TO THE AUDIO Spotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjti Apple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970 Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast Podbean: https://pharmaprescribed.podbean.com Youtube: http://www.youtube.com/@pharmaprescribedpodcast Full transcript and episode notes: https://pharmaprescribed.com/episodes ⏱️ CHAPTERS 0:00 Intro 0:35 Meet Ashish Rishi 1:00 A father's diagnosis 3:00 From neuroscience to comms 4:00 The clinical trial wake-up call 7:00 The Demand Diversity movement 9:00 Building Equity Engine 12:00 Inclusion debt explained 15:00 UK data fragmentation 17:00 Barriers and misinformation 19:00 AI-powered patient insights 26:00 Neurodivergent-friendly trials 28:00 Quickfire round 30:00 Golden rule and wrap up 👤 ABOUT ASHISH RISHI Founder and CEO of Unwritten Health and creator of the Equity Engine platform. Neuroscience MSc and former health communications specialist. Sits on the scientific advisory board of IHI READ-Y (an EU Innovative Health Initiative / Horizon Europe programme advancing inclusive clinical research) and the equity committee of the US Prader-Willi Syndrome Association. Advocate for re-engineering health inequity as an evidence and design problem. 💼 Search "Ashish Rishi" on LinkedIn 🌐 https://www.unwrittenhealth.com 🎙️ ABOUT PHARMA PRESCRIBED Pharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker. 🌐 https://pharmaprescribed.com ▶️ https://www.youtube.com/@pharmaprescribedpodcast 💼 https://www.linkedin.com/in/adamwalkerbiometrics 🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast #AshishRishi #UnwrittenHealth #InclusionDebt #HealthEquity #ClinicalTrials #ClinicalTrialDiversity #PharmaPrescribed #PatientExperience #SocialDeterminantsOfHealth #RWE #HealthInequality

Louise Callin on dementia, photos sparking conversation & making care more human | Pharma Prescribed Louise Callin — founder and CEO of ReelLife Conversations — joins Adam Walker for a warm and moving conversation about dementia, human connection and building technology that makes care more human, not less. After nearly 30 years leading technology and transformation for global corporations including American Express, Louise left to build something with more direct impact. Her mother's dementia journey inspired the idea: photos aren't a memory test, they're a conversation waiting to happen. ReelLife Conversations uses AI to turn family photographs into dementia-friendly conversation prompts — analysing each picture for colours, objects and places, then linking one photo naturally to the next. She's since secured venture capital investment and is building partnerships across the UK and internationally. Adam and Louise met at a conference — and her energy is unmistakable. 🎧 LISTEN ON YOUR PREFERRED APP Spotify → https://open.spotify.com/search/Louise+Callin+pharma+prescribed/episodes ⚠️ SWAP Apple Podcasts → https://podcasts.apple.com/gb/search?term=Louise+Callin+pharma+prescribed ⚠️ SWAP Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast Podbean → https://pharmaprescribed.podbean.com/ Youtube → https://youtu.be/wq1GShCpCYE  📖 WHAT WE COVER - The superpower Louise didn't know she had — linking one photo to the next in real time - Why photos should never be a memory test: "Do you remember when?" versus "I remember when" - The green top story — how colour, not context, unlocks connection - Turning physical albums into digital assets that work for dementia - Accessible design with no standard to follow: fear-free buttons, no menus, opens straight to use - How the app works: facial recognition, family admin naming, AI conversation prompts - Why each photo links to the next to support natural conversation flow - The carer as the third leg of the stool — and why social care struggles with retention - Louise's mum's journey — and how love led her to quietly cover up early symptoms - Why dementia statistically affects women more — as patients and as primary carers - Dr.Tommy Wood on sleep, supply and stimulation — the non-pharmacological approach - Securing VC investment for a values-driven, volume-based, low-subscription model - Sailing, mind maps and "common sense is not very common" ⏱️ CHAPTERS 0:00 Introduction & podcast mission 1:00 Meet Louise Callin — founder of ReelLife Conversations 1:30 Mission: technology that makes care more human 2:00 Her mother's dementia journey and the inspiration 2:30 Photos spark conversation — the coffee table superpower 4:00 Why the carer couldn't use the photos alone 5:00 Colours, objects and places — not just faces 6:00 Photos are a conversation waiting to happen 8:00 No memory tests: "Do you remember" versus "I remember" 9:00 The green top and turning language around 11:00 From analogue albums to digital assets 12:00 Accessible design for dementia — no written standard 13:00 Fear-free buttons and opening straight into use 14:00 Designed for two people, side by side 15:00 The family admin portal and uploading photos 16:00 Facial recognition, naming and location data 17:00 AI conversation prompts — the game changer 18:00 Linking each photo to the next 19:00 The carer as stimulus — the third leg of the stool 20:00 Every journey is unique — Uncle Geoff's story 22:00 Louise's mum: covering up early symptoms out of love 24:00 Social connection as critical — not surfacing memories 26:00 From corporate life to founder — securing funding 28:00 The volume model: small subscription, huge need 30:00 A values-driven business 31:00 Women and caregiving — menopause, sleep and stress 34:00 Women outliving men and the caregiving needle 35:00 Dementia at the forefront, like mental health before it 36:00 From pharmacological to non-pharmacological care 37:30 Quick-fire: I matter too 38:30 The water, sailing and a fish in a previous life 40:00 Golden rule: common sense is not very common 41:00 reellifeconversations.com and closing thanks 👤 ABOUT LOUISE CALLIN Founder and CEO of ReelLife Conversations, a social care technology company helping families, carers and providers create meaningful conversations for people living with dementia. Nearly 30 years in technology and transformation. 🌐 https://www.reellifeconversations.com 💼 Search "Louise Callin" on LinkedIn 🎙️ ABOUT PHARMA PRESCRIBED Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker. 🌐 https://pharmaprescribed.com 💼 https://www.linkedin.com/in/adamwalkerbiometrics #LouiseCallin #ReelLifeConversations #Dementia #DementiaCare #PharmaPrescribed #AdamWalker #SocialCare #NonPharmacological #CaregiverSupport #WomenAndDementia #DigitalHealth #HumanConnection #Alzheimers #DementiaFriendly #Wellbeing

Andreas Beust on how a small CRO covers the globe without growing | Pharma Prescribed Andreas Beust is CEO and Managing Director of GCP Service International, a Bremen-based CRO working across medicinal products, medical devices and in vitro diagnostics. He's also President of ACROS — the Association of International CROs — and a guest lecturer at the University of Bremen. He started on the biostatistics desk. He's now running the company, elected by a leader who — not yet 50 — went looking for a successor because clinical research moves too fast to leave succession to chance. In this episode Andreas makes complex things accessible, which is his stated mission. He explains the ACROS model: ten similarly-sized, like-minded CROs from the US to Europe, the Middle East, India, China and Australia, who agree that once a partner joins, their country is off-limits to the others. It lets a small CRO run trials globally — 20 concurrent studies across Spain, Italy and Portugal through one trusted partner — without ballooning into the kind of large, rigid, expensive organisation that can't serve smaller sponsors. Grow together, not bigger. He's refreshingly frank on AI: a lot of overpromise and underdeliver, quarter-of-a-million-per-seat licence fees that no small or mid-size company can pay, and real but modest gains in medical writing, programming and knowledge capture — always human in the loop. And he's honest about the thing that actually drives growth: discomfort. Curiosity, listening first, and putting yourself in the shop window of the unknown. An optimistic, grounded conversation about how the human end of this industry actually works — and how to break into it. 🎧 LISTEN TO THE AUDIO Spotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjti Apple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970 Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast Podbean: https://pharmaprescribed.podbean.com Full transcript and episode notes: https://pharmaprescribed.com/episodes ⏱️ CHAPTERS 0:00 Intro 0:35 Meet Andreas Beust 3:00 From the biostats desk to CEO 7:00 Podcasting, curiosity and listening first 11:00 Breaking into clinical research 16:00 Advice for young talent 21:00 Hiring for attitude 23:00 Leading without ego 26:00 A flexibility mindset 27:00 Building the ACROS alliance 30:00 The presidency and the mission 35:00 A communal growth model 37:00 AI in clinical trials — a reality check 42:00 Compliance, costs and human in the loop 44:00 Hope amid uncertainty 46:00 Quickfire round 50:00 Final takeaways 👤 ABOUT ANDREAS BEUST CEO and Managing Director of GCP Service International (Bremen). President of ACROS, the Association of International CROs. Guest lecturer at the University of Bremen. Biologist by training who joined GCP Service in the biostatistics department and rose to lead the company through its international expansion. Advocate for accessible clinical research and for training new talent from the ground up. 💼 Search "Andreas Beust" on LinkedIn 🌐 https://www.gcp-service.com 🎙️ ABOUT PHARMA PRESCRIBED Pharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker. 🌐 https://pharmaprescribed.com ▶️ https://youtu.be/GxVq88C6ChA 💼 https://www.linkedin.com/in/adamwalkerbiometrics 🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast #AndreasBeust #GCPService #ACROS #CRO #ClinicalResearch #ClinicalTrials #PharmaPrescribed #AIinPharma #ClinicalTrialCareers #GCP #ContractResearch

Graham Allcott on Kind, Psychological Safety & the Quiet Power of Kindness | Pharma Prescribe Graham Allcott — bestselling author of How to Be a Productivity Ninja and Kind: The Quiet Power of Kindness at Work — joins Adam Walker for a conversation about why the ruthless-boss archetype is scientifically wrong. Graham founded Think Productive, now operating across the UK, USA, Canada, Australia and the Netherlands. His latest book won the 2025 Leadership Book of the Year from the Institute of Leadership and a Business Book Award. His argument is simple and evidence-backed: kindness builds trust, trust builds psychological safety, and psychologically safe teams outperform everyone else. Adam and Graham first met at the Sussex University Kindness Conference. This is the conversation that followed. 🎧 LISTEN ON YOUR PREFERRED APP Spotify → https://open.spotify.com/episode/04glB17p7bBWVmLjlwIO7z?si=WfiLpCsPQuatGlGcV2_NQQ Apple Podcasts → https://podcasts.apple.com/gb/podcast/graham-allcott-on-kind-psychological-safety-the-quiet/id1829715970?i=1000778402287 Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/episodes/dd83fbdb-4053-468f-8486-9e346073b5f6/adam-walker%E2%80%99s-pharma-prescribed-podcast-graham-allcott-on-kind-psychological-safety-the-quiet-power-of-kindness-pharma-prescribed  Podbean → https://pharmaprescribed.podbean.com/ Youtube → https://youtu.be/1i1_TIZRBmI  📖 WHAT WE COVER - Why we got the success archetype wrong — Mr Burns, Dragon's Den and the myth of the ruthless leader - "Trust and kindness are our rocket fuel" — the company value that became a book - How trust eliminates due diligence — and the Apple purchase analogy - Why organisations without shareholders find kindness easier: Timpson, Richer Sounds, Reed - James Timpson: "The easiest way to make the numbers go up is to flog everybody" - Why charities are often the least kind places to work - The biggest source of accidental unkindness is busyness - The kindness window: why the opportunity closes the moment you notice it - Slowness isn't about speed, it's about savouring - Erling Kagge, the South Pole and the apple that connected him to the tree - How Seth Godin blurbed the book — and the watermark that nearly stopped it - Kindness starts with you: abundance versus scarcity - DJing jazz, funk and soul at Brighton Sundae ⏱️ CHAPTERS 0:00 Introduction & podcast mission 1:00 Meet Graham Allcott 1:30 The mission: thinking differently about work 2:00 Why the success archetype is scientifically wrong 3:00 Meeting at the Sussex Kindness Conference 4:00 The bridge between productivity and kindness 4:30 "Trust and kindness are our rocket fuel" 5:00 Culture without a water cooler 6:00 Psychological safety and what the research shows 8:00 Trust eliminates due diligence — the Apple analogy 9:00 What happens when trust is lost 10:00 Scandinavian workplaces, hygge and Copenhagen 12:00 The shareholder problem — family businesses do it better 13:00 James Timpson on flogging everybody 15:00 Common threads across kinder organisations 17:00 Kindness to customers, not just employees 18:30 The charity sector reality check 21:00 Attention, meetings and How to Fix Meetings 22:00 Nancy Kline's Time to Think 23:00 Podcasting and the attention economy 25:00 Busyness and kindness — do they mix? 27:00 The kindness window and the London Tube seat 28:00 Item four — the praise you never gave 29:00 Busyness as a badge of honour 30:00 Adam's back surgery and rebuilding slowly 32:00 Carl Honoré and the slow movement 33:00 Slowness is savouring, not speed 34:00 Erling Kagge, the South Pole and the apple 36:00 Seth Godin and Beyond Busy 38:00 The advice that named the book 39:00 The watermark that nearly stopped the blurb 40:00 "Blurbs help the author walk taller" 42:00 Kindness starts with you 44:00 Abundance versus scarcity 45:00 "There is enough. I am enough." 46:00 Rev Up for the Week 47:00 Quick-fire: book the ticket 47:45 DJing at Brighton Sundae 48:30 Golden rule: stay curious 👤 ABOUT GRAHAM ALLCOTT Author, speaker and entrepreneur. Founder of Think Productive. Author of How to Be a Productivity Ninja and Kind: The Quiet Power of Kindness at Work — 2025 Leadership Book of the Year. Resident DJ at Brighton Sundae. 🌐 https://www.grahamallcott.com 📧 Rev Up for the Week — free Sunday newsletter 🎧 brightonsundae.com 🎙️ ABOUT PHARMA PRESCRIBED Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker. 🌐 https://pharmaprescribed.com 💼 https://www.linkedin.com/in/adamwalkerbiometrics #GrahamAllcott #Kind #KindnessAtWork #ThinkProductive #ProductivityNinja #PharmaPrescribed #AdamWalker #PsychologicalSafety #Leadership #WorkplaceCulture #SethGodin #Busyness #SlowMovement #Trust #Wellbeing

Adam Walker interviews namesake Adam Walker; GMP, Sepsis & 900k NHS Doses a Year | Pharma Prescribed Two Adam Walkers, one conversation. This week the host is joined by his namesake — Adam Walker, Qualified Person, Head of Development and Innovation at the North East and North Cumbria Medicines Manufacturing Centre, and co-founder of the Help Me GMP educational platform. Adam qualified as an NHS pharmacist in 2003 and quickly realised the clean room, not the ward, was where he could do the most good. In this episode he explains the quiet revolution underway in NHS pharmaceutical manufacturing: a new hub-and-spoke model, one of four national aseptic pathfinder hubs, and a brand-new facility in Northumberland going live in 2027 — built to produce around 150,000 chemotherapy doses and up to 750,000 ready-to-administer antibiotic doses a year. The patient impact is immediate. A ready-made antibiotic bag pulled from a fridge means the one-hour door-to-needle target for suspected sepsis is met, and nurses get 12–15 minutes per dose back for patient care. Then the conversation turns personal. Adam shares his "why" — his mother's Grade 4 metastatic bowel cancer diagnosis in 2003, her remarkable response to the FOLFOX regimen, and the nine extra years it bought: his wedding, meeting his first son. It's why he gets up in the morning. He also opens up on mentorship, Annex 1, and building Help Me GMP for the "TikTok generation" of pharma professionals. Two disciplines — GMP and GCP — one shared mission: getting the right medicine to the patient at the right time. 🎧 LISTEN TO THE AUDIO Spotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjti Apple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970 Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast Podbean: https://pharmaprescribed.podbean.com Full transcript and episode notes: https://pharmaprescribed.com/episodes Youtube: https://youtu.be/2MoNyxxkDiE    ⏱️ CHAPTERS 0:00 Intro 0:35 Meet Adam Walker (QP) 1:00 Finding pharma manufacturing 9:00 Development & innovation: the NENC hub 15:00 Patient impact and the sepsis window 18:00 A personal why: his mother's cancer and FOLFOX 21:00 Mentors and career shapers 27:00 The Help Me GMP mission 31:00 Creating content with AI — the GMP way 33:00 Quick fire round 36:00 Golden rule and wrap up 👤 ABOUT ADAM WALKER (GUEST) Qualified Person and pharmaceutical quality leader. Head of Development and Innovation at the North East and North Cumbria Medicines Manufacturing Centre, leading the build of next-generation NHS manufacturing facilities. Co-founder of Help Me GMP, delivering free, practical GMP training worldwide. NHS pharmacist since 2003, specialising in GMP manufacturing, aseptic processing and medicine supply. 💼 Search "Adam Walker Help Me GMP" on LinkedIn 🌐 https://www.whatisgmp.com ▶️ Help Me GMP on YouTube 🎙️ ABOUT PHARMA PRESCRIBED Pharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker. 🌐 https://pharmaprescribed.com ▶️ https://www.youtube.com/@pharmaprescribedpodcast 💼 https://www.linkedin.com/in/adam-walker-2327951/ 🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast #AdamWalker #HelpMeGMP #GMP #NHS #AsepticProcessing #MedicinesManufacturing #PharmaPrescribed #PatientSafety #Chemotherapy #Sepsis #QualifiedPerson #Pharma

Lisa Kerr on why 95% of eligible patients never join a clinical trial | Pharma Prescribed Lisa Kerr is Head of Patient Engagement at Evinova, AstraZeneca's health tech business — a PhD chemist who climbed to global project director, hit a cliff edge, and came back with a mission. In this episode Lisa talks openly about the divorce, the clinical depression, and the three months as an outpatient at the Priory that reshaped her career. She founded AstraZeneca's Safe Space employee resource group after one Workplace post she thought would end her career — and built mental health navigation tools that scaled globally. She then turns that lived experience on the industry itself: only 5–7% of eligible patients ever join a clinical trial, and that number has barely moved in a decade despite digitisation and healthcare transformation. Lisa explains the EACH framework, why patients are the real investors in a trial (time, health, trust — given for free), and why AI has just destroyed pharma's last excuse for not designing trials with patients. Honest, funny, and unusually direct. No soundbites, no spin. 🎧 LISTEN TO THE AUDIO Spotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjti Apple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970 Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast Podbean: https://pharmaprescribed.podbean.com Full transcript and episode notes: https://pharmaprescribed.com/episodes ⏱️ CHAPTERS 0:00 Intro 0:35 Meet Lisa Kerr 1:30 A mission built on lived experience 2:50 From PhD chemist to global project director 4:20 The cliff edge: divorce, depression, the Priory 5:50 "Ask people how they are twice" — the colleague who saved her 8:50 The mental health access crisis 11:40 Building Safe Space at AstraZeneca 16:10 The navigation tools that scaled globally 20:10 Purpose, energy and humour 22:45 Lessons from the Priory 26:40 Patient engagement: being the voice in the room 29:10 The EACH framework and patients as consumers 30:50 Why only 5–7% of eligible patients ever join a trial 32:35 When the system fails even the well-informed 35:30 AI kills the industry's last excuse 38:10 Misinformation, hallucination and pharma's silence on social 41:50 Quick fire round 44:20 Where to find Lisa 👤 ABOUT LISA KERR Head of Patient Engagement at Evinova (AstraZeneca). PhD chemist, 20+ years across global pharma and health tech. Founder of AstraZeneca's Safe Space ERG and the Evinova I&D network. Advocate for LGBTQIA+ rights, neurodivergent communities and trauma survivors. Charity trustee. Singer in rock and pop covers band The Torrists. 💼 Search "Lisa Kerr" on LinkedIn 🎸 The Torrists — on Instagram and Facebook 🎙️ ABOUT PHARMA PRESCRIBED Pharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker. 🌐 https://pharmaprescribed.com ▶️ https://www.youtube.com/@pharmaprescribedpodcast

Alen Lalic on Engineering Clinical Trial Enrollment with Predictive AI | Pharma Prescribed Alen Lalic — founder and CEO of Clinical Trial Scan, Olympic fencer and patent-pending inventor of Dyno AI — joins Adam Walker for one of the most data-driven conversations on the Pharma Prescribed Podcast. Alen's path to clinical trials started with Facebook ads, a friend called Artyom, and $5–7 million in advertising spend across 50 studies. When margins got squeezed, he didn't walk away — he took control of the funnel, built a predictive AI that calculates the true cost per enrollment before a study starts, and filed a patent on the methodology. His golden rule: just show up. Kobe Bryant said it best. 🎧 LISTEN ON YOUR PREFERRED APP Spotify → https://open.spotify.com/episode/3sRsBTqdRbRK7sTzhjSWi1?si=TQgkyijsS-WTX7OXGwoC0g Apple Podcasts → https://podcasts.apple.com/gb/podcast/alen-hadzic-on-engineering-clinical-trial-enrollment/id1829715970?i=1000775363752  Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast Podbean → https://pharmaprescribed.podbean.com/ Youtube → https://youtu.be/02tkkvXY4VU?si=-6PyzKLqEqWK-E-T   📖 WHAT WE COVER - $5–7M in Facebook ad data across 50+ clinical trials — and what it revealed - Dyno AI: predicting the true cost per enrolled patient before you spend a dollar - The seven funnel steps from ad click to enrollment — and why each probability matters - Monte Carlo simulations for enrollment cost forecasting - Why a 10% deviation in one funnel step can double your cost per patient - Hot leads vs cold databases: why speed to call changes everything - 70% answer rate across nine calls — but only if you call in the evening - The Colombia call centre: American Colombians running three call blocks a day - Why most AI in clinical trials doesn't work — and how Alen's actually does - Olympic fencing, coach Alexey Cheremsky and waking up at 4am - Bosnian father, French literature PhD mother and never listening to advice - Recording a death metal album while scaling a clinical trial startup - Patent pending on the cost per enrollment methodology ⏱️ CHAPTERS 0:00 Introduction & podcast mission 1:00 Meet Alen Lalic — founder of Clinical Trial Scan 2:00 Former Olympic fencer, musician, writer, drummer 3:00 How sport and consulting gave him a unique perspective 4:00 Finding clinical trials through Spravato and COVID 5:00 Affiliate marketing: running ads for the biggest recruitment vendors 6:00 $5–7M in advertising data across 50+ studies 7:00 Margins squeezed — so he took control of the funnel 8:00 Understanding the real cost per enrollment 9:00 Why questionnaire design kills your ad performance 10:00 Cost per lead by city: $66 Detroit, $52 Miami 12:00 The algorithm, keywords and why simple ads outperform 13:00 Dyno AI: protocol upload to funnel prediction 14:00 The seven funnel steps — call to enrollment 16:00 Dropout, concierge and speed to call 17:00 Why cold databases fail and hot leads win 18:00 48-hour contact window — the critical threshold 19:00 End-to-end delivery and site-centric pricing 20:00 Small funnel deviations = massive cost changes 21:00 Colombia call team: bilingual, driven, three blocks a day 24:00 Initiation fees, difficulty scores and transparent pricing 25:00 AI hype reality check — "we are not an AI company" 26:00 Why small databases won't save your study 27:00 How Dyno's AI actually trains and improves 28:00 Monte Carlo simulations and confidence intervals 29:00 Expanding: Colombia, Brazil and LATAM 31:00 Mentors: coach Cheremsky, parents, the clinical trials community 34:00 Quick-fire: let life do the work — stop forcing outcomes 36:00 Show up, good attitude, bring yourself 37:00 Music: Iron Maiden changed everything — recording an album 38:00 Golden rule: show up — Kobe Bryant said it best 41:00 dyno.clinicaltrialscan.ai and closing thanks 👤 ABOUT ALEN LALIC Founder and CEO of Clinical Trial Scan. Creator of Dyno AI (patent pending). Former Olympic fencer. Columbia University. Vlerick Business School. 🌐 https://dyno.clinicaltrialscan.ai 💼 Search "Alen Lalic" on LinkedIn 🎙️ ABOUT PHARMA PRESCRIBED Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker. 🌐 https://pharmaprescribed.com 💼 https://www.linkedin.com/in/adamwalkerbiometrics #AlenHadzic #ClinicalTrialScan #DynoAI #PatientRecruitment #ClinicalTrials #PharmaPrescribed #AdamWalker #CostPerEnrollment #MonteCarlo #DigitalAdvertising #FacebookAds #OlympicFencer #LifeSciences #ClinicalResearch #PatentPending

Dr. Pat Boulogne on Functional Medicine, Fasting Since 17 on Zero Medications @71 | Pharma Prescribed Dr.Pat Boulogne — performance optimisation strategist, functional medicine expert and bestselling author — joins Adam Walker for one of the most practical wellbeing conversations on the Pharma Prescribed Podcast. Dr.Pat is 71, takes zero medications, works 14-hour days with full mental clarity, and has spent 30+ years helping high performers close the gap between where they are and where they want to be. Her father wanted her to be an electrical engineer. She chose to become an engineer of life and health instead. Her approach is pharma unprescribed. 🎧 LISTEN ON YOUR PREFERRED APP Spotify → https://open.spotify.com/episode/3Xda2P6nkvkSzHwKyRr02f?si=8sT0tSfNQf-E1m6MApUnwQ Apple Podcasts → https://podcasts.apple.com/gb/podcast/dr-pat-boulogne-on-functional-medicine-fasting-since/id1829715970?i=1000774232267 Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast 📖 WHAT WE COVER - 71 years old, zero medications, 14-hour days — how she does it - Root cause medicine vs symptom masking: the sleep medication story - Intermittent fasting since age 17 — before anyone called it that - How to pair foods so your body isn't stressed — and why timing matters - Alkaline tide: why you crash after lunch and what to do about it - The three brains: lizard, mammalian and conscious — and how they talk - Why affirmations only work if you ask "why" at the end - The organic broccoli dating analogy — and the woman who stole it - "If it's brown, don't eat it in the morning" - Adam's back surgery, the body keeping score and the V-shaped trees - Be true to yourself — the golden rule ⏱️ CHAPTERS 0:00 Introduction & podcast mission 1:00 Meet Dr.Pat Boulogne — performance optimisation strategist 2:00 Mission: saving lives through physical, mental and emotional health 3:00 From electrical engineering to engineer of life and health 4:00 71, zero medications, sharp brain — how 5:00 University of Michigan and the question that got her uninvited 6:00 Outside-the-box medicine and why she never looked back 7:00 85% of headaches are metabolically involved 8:00 The sleep medication story: first full night in weeks 9:00 Intermittent fasting since 17 — one meal a day 10:00 Water intake calculated by body weight 11:00 Brain performance: when to study, eat and exercise 12:00 Alkaline tide: why food makes you crash 13:00 In-a-Gadda-da-Vida: exercise to a heartbeat 14:00 Bread, self-regulation and pushing away from the table 15:00 Scarpetta la piatra: how Italians eat bread right 16:00 Microbiome, labels and knowing your food sources 17:00 Corn syrup, ultra-processed foods and why labels lie 18:00 Injured gut: probiotics won't save you 19:00 Dairy: raw milk vs dead milk — source matters 21:00 Body signals: bloating, cramps and what they mean 22:00 Foot adjustment: five days pain-free after 20 years 23:00 Adam's back surgery and the body keeping score 25:00 Three brains: lizard, mammalian and conscious 26:00 Affirmations plus "why" — rewiring the mammalian brain 28:00 The V-shaped trees, the ring and Adam's daily ritual 30:00 Golfer's pickup and protecting your pelvis 32:00 "I open the fridge and look in the medicine cabinet" 34:00 Organic broccoli is like dating — the story 36:00 Food as medicine: lifestyle not diet 37:00 "Play with your grandkids or watch them?" 39:00 Quick-fire: go to school sooner, say what you think 40:00 Honesty, integrity, action — and cooking 41:00 Golden rule: be true to yourself 👤 ABOUT DR. PAT BOULOGNE Performance optimisation strategist. Functional medicine expert. Author of Why Are You Sick, Fat, and Tired? 30+ years clinical experience. 📚 Amazon UK and US 💼 Search "Dr Pat Boulogne" on LinkedIn 🎙️ ABOUT PHARMA PRESCRIBED Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker. 🌐 https://pharmaprescribed.com 💼 https://www.linkedin.com/in/adam-walker-2327951/ #DrPatBoulogne #FunctionalMedicine #PerformanceOptimisation #PharmaPrescribed #AdamWalker #IntermittentFasting #RootCause #Wellbeing #Nutrition #ThreeBrains #Affirmations #OrganicFood #Microbiome #GutHealth #HealthyAging

Andy York on AI, Data Science & Why 80% Accuracy Isn’t Good Enough | Pharma Prescribed Adam Walker sits down with Andy York — statistician, clinical data science leader, and former VP of Clinical Data Science at Novo Nordisk — for a masterclass in where pharma's data revolution has been, where it's heading, and why the AI hype needs a reality check.
With over 30 years spanning Roche, Covance, and Novo Nordisk, Andy now advises Verisian, a company building next-generation AI and traceability tools for clinical reporting. He brings rare historical depth and hard-won perspective to one of the industry's most pressing questions: can we actually trust AI with patient safety?
In this episode: Why 80% AI accuracy equates to a process out of control — and what the Six Sigma reality check means for drug development
The journey from paper CRFs and carbon copies to EDC, CDISC standards, and AI-assisted programming
SAS vs R vs Python — what the shift to open source really means for regulatory submissions
How guardrails, not raw AI, are the key to hitting 95%+ accuracy in clinical reporting
The future of statistical programming: from code developers to validators
Why pharma's AI revolution will realistically take a decade — and what to do in the meantime
Career advice for the next generation entering clinical data science Whether you're a statistical programmer, data scientist, biometrician, or simply curious about AI's real role in drug development, this conversation will challenge your assumptions and sharpen your thinking. 🎙️ Pharma Prescribed is hosted by Adam Walker, biometrics consultant and independent voice in clinical research and healthcare leadership.
🔗 Listen on all platforms: pharmaprescribed.com 📧 Connect with Adam: https://www.linkedin.com/in/adam-walker-2327951/ ⏱️ CHAPTERS
00:00 Introduction 01:00 Meet Andy York — Career & Mission 02:00 Why Pharma? The Noble Cause Behind the Data 04:30 Lessons From 30 Years — Advice for Newcomers 05:30 From Paper CRFs to EDC: How Data Collection Evolved 07:00 Standards, CDISC, SAS & the Programming Revolution 08:30 AI in Pharma — The Reality Check 10:00 The 80% Problem & Six Sigma Thinking 11:00 Guardrails: How to Make AI Reliable in Clinical Reporting 13:00 Human in the Loop — The FDA's Stance on AI Submissions 15:00 Parallel Streams & Freeing Up Resource Through Automation 17:00 Expanding Drug Indications With AI Efficiency 18:00 Conference Trends — The Move From SAS to R 20:00 Open Source vs Validated Systems — Regulatory Perspectives 23:00 SAS, R, Python — The Right Language for the Right Job 24:30 Future Roles: From Programmer to Data Scientist 27:00 The Next Generation — Gamers, AI Natives & Skills for Tomorrow 29:00 Science Fiction Becoming Science Fact 30:30 Verisian's Roadmap — What's Coming Next 32:30 Andy's Closing Advice for Programmers at Every Stage 🏷️ TAGS
clinical data science, statistical programming, AI in pharma, drug development, clinical trials, SAS vs R, open source pharma, CDISC standards, regulatory submission, FDA AI, Novo Nordisk, Verisian, biometrics, data science careers, pharma podcast, clinical research, Adam Walker, Pharma Prescribed, Andy York, EDC, SDTM, ADaM, PharmaVerse, R consortium, double programming, AI accuracy, patient safety, pharmaceutical industry, clinical data management, real world evidence, pharma careers